William Horan

Company: Bristol Myers Squibb

Job title: Clinical Science Program Lead, Neuropsychiatry

Seminars:

Cobenfy Beyond Psychosis: What is the Potential of Muscarinics to Address the High Unmet Need for Cognitive & Negative Symptom Management? 5:00 pm

Exploring promising avenues for Cobenfy to target symptoms beyond psychosis Outlining future directions for Cobenfy to be investigated for negative schizophrenia symptoms and cognitive-related symptoms across psychiatry: how could it be used to achieve functional recovery? Addressing key obstacles to anticipate and address when targeting negative symptoms and cognitive deficits in clinical populationsRead more

day: Day One PM